Correlation Between C Rad and AlzeCure Pharma
Can any of the company-specific risk be diversified away by investing in both C Rad and AlzeCure Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining C Rad and AlzeCure Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between C Rad AB and AlzeCure Pharma, you can compare the effects of market volatilities on C Rad and AlzeCure Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in C Rad with a short position of AlzeCure Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of C Rad and AlzeCure Pharma.
Diversification Opportunities for C Rad and AlzeCure Pharma
0.81 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between CRAD-B and AlzeCure is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding C Rad AB and AlzeCure Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AlzeCure Pharma and C Rad is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on C Rad AB are associated (or correlated) with AlzeCure Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AlzeCure Pharma has no effect on the direction of C Rad i.e., C Rad and AlzeCure Pharma go up and down completely randomly.
Pair Corralation between C Rad and AlzeCure Pharma
Assuming the 90 days trading horizon C Rad AB is expected to generate 0.29 times more return on investment than AlzeCure Pharma. However, C Rad AB is 3.46 times less risky than AlzeCure Pharma. It trades about 0.07 of its potential returns per unit of risk. AlzeCure Pharma is currently generating about -0.23 per unit of risk. If you would invest 2,950 in C Rad AB on September 3, 2024 and sell it today you would earn a total of 75.00 from holding C Rad AB or generate 2.54% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
C Rad AB vs. AlzeCure Pharma
Performance |
| Timeline |
| C Rad AB |
| AlzeCure Pharma |
C Rad and AlzeCure Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with C Rad and AlzeCure Pharma
The main advantage of trading using opposite C Rad and AlzeCure Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if C Rad position performs unexpectedly, AlzeCure Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AlzeCure Pharma will offset losses from the drop in AlzeCure Pharma's long position.| C Rad vs. CellaVision AB | C Rad vs. Biotage AB | C Rad vs. Boule Diagnostics AB | C Rad vs. RaySearch Laboratories AB |
| AlzeCure Pharma vs. Stille AB | AlzeCure Pharma vs. Midsona AB | AlzeCure Pharma vs. Precio Fishbone AB | AlzeCure Pharma vs. C Rad AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| CEOs Directory Screen CEOs from public companies around the world |